Pharmaceutical Chemistry

David Richard is an American entrepreneurial engineer who has been awarded over 15 patents in his career. His patents span the chemical, optical, electro-optical, automotive, pharmaceutical and healthcare technical disciplines. His most recent patents are for the development of techniques for an Apparatus and Method for Preparing Cosmeceutical Ingredients Containing Epi-Dermal Delivery Mechanisms entailing unique methods for the continuous creation of surface charged vesicles. The son of a lumber company manager in Connecticut, he developed an interest in science during his school days. An avid reader, he was deeply influenced by the books “A Single Pebble” by John Hersey and “The Design of Everyday Things” by Donald Norman, which in part influenced him to become a more inquisitive scientist. The unwavering support of one his teachers also helped him to recognize his calling in the scientific development field. He received his Bachelor of Science degree in Engineering from The University of New Haven and his Masters in Material Science from Rensselaer Polytechnic Institute. His career has spanned a collage’ of industries and disciplines. As CTO of VTEC, Mr. Richard was responsible for disruptive product development and innovation in Asia. Prior to joining VTEC, Mr. Richard has served in positions including: President, Plastec, Inc., a diversified development and engineering company in polymer optics; VP of Operations, Eye Technology Incorporated, a leader in the medical devise intraocular lens industry; President, Diverse Technologies, Inc., an innovator in molecular delivery of pharmaceuticals; and VP for Engineering and F.D.A. Compliance for IOLAB Corporation, which became the origin of Johnson & Johnson’s ophthalmic franchise.

David Richard developed an interest in science during his school days. An avid reader, he was deeply influenced by the books “A Single Pebble” by John Hersey and “The Design of Everyday Things” by Donald Norman, which in part influenced him to become a more inquisitive scientist. The unwavering support of one of his teachers also helped him to recognize his calling in the scientific development field.

Prof. Dr. Panayiotis Zavos is a highly educated and motivated individual. He received his B.S. degree in Biology, his M.S. degree in Biology-Physiology and his Education Specialist in Science degree (Ed.S.) from Emporia State University. He earned his Ph.D. degree in Reproductive Physiology (Medicine), Biochemistry and Statistics from the University of Minnesota in the Twin Cities, USA. He also earned an MBA degree. He is currently a Professor Emeritus at the University of Kentucky in Reproductive Physiology/Andrology and other Assisted Reproductive Technologies (ARTs). Prof. Zavos is also the Honorary Chairman of the Zavos Organization, USA, the Director and Chief of Andrology at the Andrology Institute of America, President and CEO, of ZDL, Inc. USA, Founder & GM of Repromed International (Cyprus), and President of ZDL Global Ltd., also a Cyprus Corporation. He also serves as a member of the Board of Directors and advisor of several Companies and Foundations too numerous to mention. Professor Zavos has a long career as a World class reproductive specialist and he has devoted more than 40 years of his life to academia and research and clinical services. Dr. Zavos is one of the leading fertility specialists in the world and he has become one of the most looked-to doctors for men and women who are struggling with conception difficulties. Dr. Zavos is currently serving among other posts as a Life-long Board Member of the Middle East Fertility Society, is a past Board Member of the China Academy of Sciences, Advisor to the Kuwait Medical Genetic Center and Scientific Advisor to the Albar Medical Center in Saudi Arabia among many others. He was awarded the first ever Honorary Professorship by the Chinese Academy of Science awarded to an American Scientist by the Chinese Academy of Science and more recently received an Honorary Professorship by the Shri Medical University in Uttar Pradesh in India. He is also the Founder and Director of the Zavos Organization, an Organization that disseminates scientific and clinical information globally for a variety of reproductive difficulties. It’s no wonder that Dr. Zavos has picked up such accolades as the World Father of Andrology, the Father of Human cloning, a Distinguished Fulbright Scholar, the Distinguished Alumnus Award from Emporia State University, the Student Leadership Award from the University of Minnesota, recipient of the Paul Harris Fellow Award, and many many others. Dr. Zavos has a large volume of scientific collaborations nationally and internationally and his publications have appeared in more than fifteen languages, globally. He is a current or past member of a large number of professional and scientific societies, among them, the American Fertility Society, the American Society for Reproductive Medicine, the American Society of Andrology, the Middle East Fertility Society, The Japanese Society of Andrology, International Society of Cryobiology and many others. He has received a great deal of media Worldwide coverage both within the scientific and reproductive arena and the mainstream press for his many scientific accomplishments and pioneering ventures on stem cell research and human cloning technology development. Dr. Zavos was the first scientist to ever successfully perform intra-uterine inseminations in humans, the first to create the first human SCNT prepared embryos for reproductive purposes and use them for ET in women. He is a true pioneer in many other areas, too numerous to mention. Professor Zavos is fluent in English and Greek and is a very inspirational, dynamic, powerful, informed and articulate speaker and has been an Invited speaker and participated at a large number of speaking engagements over the years, worldwide. His speeches and debates that appeared globally have covered a large spectrum of topics dealing with human reproduction, reproductive technologies, and other high-tech topics. He has received a great deal of media coverage both within the scientific and reproductive arena and the mainstream press for his many scientific accomplishments and pioneering ventures. He has addressed the Congress of the United States twice, the American Academy of Sciences, participated at the Oxford Union Debates and has made many television and radio appearances from National Public Radio to CBS 60 Minutes, Dateline NBC, CNN News, CNN International, CBS Face the Nation, BBC World, BBC Talking Point, The Lary King Show, The View with Barbara Walters and many others too numerous to mention. No doubt, Professor Zavos is recognized worldwide as a leading researcher, a public speaker, a pioneer and a strong authority in the areas of male reproductive medicine, gamete physiology, male infertility, smoking and reproduction, Andrology and study of human reproduction along with other ART procedures, including ICSI, PGD, SCNT and other state-of-the-ART procedures. He is a true leader in his field and a World class scientist and pioneer! He is a phenomenal human being and one of a kind. Congratulations!!!

Reproductive Specialist in various forms of Assisted Reproductive Technologies and the “Father of Andrology”, he has been very actively involved in the areas of Assisted Reproductive Technologies, Procreation and the Reproductive Medicine arena for over 45 years, particularly working in the diagnosis and treatment of human infertility with emphasis in male infertility and possible modes for establishing and maintaining a pregnancy.

Prof. Dr. Max Welling is a research chair in Machine Learning at the University of Amsterdam and a VP Technologies at Qualcomm. He has a secondary appointment as a fellow at the Canadian Institute for Advanced Research (CIFAR). Max Welling has served as associate editor in chief of IEEE TPAMI from 2011-2015. He serves on the board of the Neurips foundation since 2015 and has been program chair and general chair of Neurips in 2013 and 2014 respectively. He was also program chair of AISTATS in 2009 and ECCV in 2016 and general chair of MIDL 2018. He is a founding board member of ELLIS. Max Welling is recipient of the ECCV Koenderink Prize in 2010. He directs the Amsterdam Machine Learning Lab (AMLAB), and co-directs the Qualcomm-UvA deep learning lab (QUVA) and the Bosch-UvA Deep Learning lab (DELTA). He has over 300 publications in machine learning and an h-index of 68.

Drug Discovery, Pharmaceutics, Pharmaceutical science, neural networks

Dr. Shamim Ahmad is a is a very well known personality in the field of Ophthalmic Microbiology. He is currently serving as a very senior distinguished Professor of Microbiology ,Superintendent (Examinations) Faculty of Medicine & Officer In-Charge Microbiology Section , Institute of Ophthalmology, J.N. Medical College , Faculty of Medicine , Aligarh Muslim University , Aligarh ,India since January,10,1983 . He also contributed his services as Teacher / Officer In-Charge (Administration), Manager , Blind School and many other academic & administrative positions at Aligarh. Beside, he was deputed to serve as Faculty for more than 5 years abroad at Faculties of Medicine in Libya and Saudi Arabia. After earning his Ph.D. degree in 1982, he obtained his Post Doc. training in various Departments of clinical and applied Microbiology at 7 Universities of world repute in 6 countries, being recipient of at least 6 International Fellowships including "DAAD (W. Germany) , "JSPS"(Japan)"ROYAL SOC. London"(UK),"DAAD"(Germany), "TUBA" (Turkey) and "SAIA" (Slovak Republic). Beside, regular Undergraduate (MBBS) and Post Graduate (MS & DO) medical students and some Professional Courses (DOA) teaching ,he has been actively engaged in the teaching & practical Classes of some of M.Sc., M.Phil. and Ph.D. programmes in India and abroad . Professor Ahmad's research work mainly involved Multi-resistant Eye Pathogens including Super Bugs MRSAs and their alternative treatment with newer antibacterial and innovative natural products especially the "Honey". He has a credit of publishing many papers , books and Book -Chapters and Supervised /Co-supervised of about 52 theses students beside presenting many papers at National and International conferences having being visited about 30 countries for academic purpose. Currently, Prof. Ahmad is honored to be Organizing Committee Member(OCM) of various Internal Conferences beside being member in the Editorial team including Chief Editor of at least 78 International Journals of world repute.

Bacterial and Fungal Infections of the Eye and their Chemotherapy, Molecular Aspect of antibiotic resistance and pathogenicity including biofilms production among of Ocular Bacterial pathogens especially Staphylococci particularly Methicillin-Resistant Staphylococcus aureus (MRSA), Exploration of newer and newer Antibiotics ,Medicinal Plants and Unani Formulations and Natural Products especially Honey for their antimicrobial activity against multi-resistant super bugs in Medicine, including Ophthalmology.

Dr Laurent Désaubry is a CNRS research director in the University of Strasbourg in France (website: http://desaubry.u-strasbg.fr/) and adjunct professor at Tianjin University of Science and Technology (TUST) in China. After a Ph.D. degree in medicinal chemistry at Strasbourg University and postdoctoral internership at SUNY at Stony Brook, USA and he Strasbourg he got a CNRS Research Senior Scientist at CNRS. He was promoted CNRS research director (corresponds to full professor) in 2014, and became also adjunct professor at TUST in 2015. He has published more than 90 publications and has been serving as an editorial board member of Frontiers in Chemistry, Medicinal Chemistry, Current Chinese Chemistry and The Open Medicinal Chemistry Journal.

Development of prohibitin ligands to treat cancers, cardiac and immunological disorders

Canan Nebigil is a Director of Research at CNRS. After her Pharm.D degree, she obtained her PhD at the University of Tennessee, USA and postdoctoral trainings, including at Duke University, NIH, Bethesda, and IGBMC, Strasbourg. Her team has been created with ATIP/Avenir CNRS, a young investigator award in Strasbourg. Her team has identified several fundamental mechanisms by which prokineticin signaling is involved in heart development and diseases associated with drug discovery. She obtained several scintific awards including, FRM, ESC, and CNRS. She is a coordinator of a EU project. She has 56 publications (H:28) and is editor of several journals. Her team was the first to explore the role of a new hormone, prokineticin, on cardiac physiopathology and metabolic disorders.

Discovery and Cardioprotective Effects of the First Non-Peptide Agonists of Prokineticin Receptor-1 (PKR1)

Franz-Josef Meyer-Almes has completed his PhD at the age of 28 years from University of Goettingen. He has 10 years experiences in biotech and pharma companies. He is Professor for Physical Biochemistry and has published more than 40 papers in reputed journals and holds more than 10 patents and patent applications.

Protein-ligand binding kinetics

Scientist Doctor Alaa Y. Ghidan, I received my PhD. in Nanotechnology, recently I've finished a training for professional in Pharmaceutical industry. I have published about 40 scientific papers including chapter in a book about bionanotechnology. I am the head of Innovation and Creativity Sector in Arab World and Academics union. Moreover; I do my researches at The Higher Council for Science and Technology. Research Interest, Nanomaterials Synthesis, Nanomaterials, Characterization, Natural Products Research, Nano-medicine, Diabetes and its prevention, Anti-cancer, Antimicrobial Activity, Academic awards, Internships Award and Best Researcher Award in Nanomedicine, 2020, India. Innovation in Education Award, 2019,International Award , India. Leadership Award and Best Researcher Award in Nanomedicine, 2019, International Award, India. Guinness Record, Nanosatellite Project at Kingdom Saudi Arabia. Awarded for Scientific Day (Best Student in Research) presented by Prof. Azmi Mahafzah, Head of the institution, The University of Jordan, 2018. Outstanding student award presented by Prof. Waleed Al-Ma'ani, Head of the institution, The University of Jordan- 2001. Friendship Award presented by England Government Under supervision of Prof. Sawsan Al-Majali, 2001. Awarded best for (School student in volunteering) Alsabelah Award, presented by his Highness Prince Al-Hassan. 1997. I have a Funded Project, Shoman Foundation, 20,000 JD, (2020-2022),Nanomaterials as Anticancer.

Nanotechnology

Mr. Fernando Garcilita Núñez is a seasoned executive, business owner, serial entrepreneur, customs agent and international logistics operator. Exceeding twenty years of expertise providing robust international trade services to clientele in highly-demanding industries such as oil & gas, pharmaceutical, automotive, agribusiness, military equipment, intelligence technology. Mr. Garcilita is the President & CEO of PetroM Corp (www.petrom.us) a multi-industry holding that encompasses a variety of operative divisions such as PetroM Logistics (www.petromlogistics.com), PetroM Intelligence Systems (www.petromintelligence.com), PetroM Trading (www.petromtrading.com), PetroM Energy (www.petromenergy.com), and of PetroM Pharma (www.petrompharma.com). Mr. Garcilita also serves as the Vice President & Co Founder of PetroM Renewable (www.petromrenewable.com), another division of PetroM Corp. Mr. Garcilita is also a member of Singularity University, a member of the Advisory Board in International Trade of The Solomon Brokerage Firm, and a Co Founding Partner at Mass Media Division. Social Media: Twitter: https://twitter.com/FerGarcilitaN LinkedIn: https://linkedin.com/in/fernandogarcilita Facebook: https://facebook.com/FernandoGarcilitaNunez AngelList: https://angel.co/fernando-garcilita-nunez Flipboard: https://flipboard.com/@FerGarcilita Singularity University: https://singularityuglobal.org/profile/fernando-garcilita-nunez

Fernando Garcilita Núñez CEO & Founder of PetroM Corp Mexico City, Mexico | Laredo, TX, USA

Mr. De la Parra is an entrepreneur focused on Information Technology, Education and Health. He is creative, results-driven and has 16+ years of Digital Strategy experience in architecture and implementation. Mr. De la Parra serves as Chief Information Technology Officer and is a member of the Advisory Board at the Kala Institute. He is the COO and Co-founding Partner at The Solomon Brokerage Firm and leads as CEO at Mass Media Division and at De la Parra Mobile Solutions. He is the former President & Co-founder of PetroM Renewable, and served as Vice President of Operations & Strategy at PetroM Corp across all of its divisions, including PetroM Logistics. He is the former COO & Co-founder at RegenerAge Clinic & RegenerAge Beauty. Mr. De la Parra is the former CEO & Founder at Astrum Salud Móvil and its Telemedicine service Astrum Móvil, former Digital Strategy Director & Co-founder at Dr. Jois, BiorganicAging, What Skin Needs/WSN International Pty. Ltd. He also served as a member of the Board of Advisors and is former Chief Marekting Officer at ReAnima Advanced Biosciences and served as Digital Media Director at Bioquark, Inc. He also served as the Latin America Region Manager and Digital Strategy adviser at CardiacSense and is former CITO & Senior Partner at Cerezo Editores. Within the academic and educational fields, Mr. De la Parra acted as the Executive Vice President: Executive Chairman of the WAMS Mobile Health Division, WAMS Chief Coordinating Officer, a member of the WAMS Executive Council (WAMS Executive Board), a member of the WAMS Education & Training Board (ETB), a member of the WAMS Editorial Board, an Honorary Member of the Academy Faculty FWAMS, an Honorary Fellow of the Academy & is also a Senior Partner at WAMS, The World Academy of Medical Sciences. He is also an Advisory Board member, functioned as the Chief Operating Officer and is a Co-founding Partner at The Reprogramming Medicine Association. Mr. De la Parra is also a member of Singularity University and of OpenExo. In relation to the organizations that Mr. De la Parra has collaborated with for social impact and empowerment, he is a member of the Laurentia Project and of Cerebro Mexico, he serves as an Advisory Board member of the Lifeboat Foundation, as an Advisory Board member of the Future Worlds Center – Cyprus Neuroscience & Technology Institute (Senior TV Program), while also being a Federated member of the International Longevity Alliance and a member of the Transhumanist Party. He is a voting citizen and is running for Mayor & future Parliamentary Candidate at Asgardia. He is the Chief Digital Strategy Officer and Member of the Board of Advisors at the Transdisciplinary Agora for Future Discussions, a member of the Web Committee at the Life Extension Advocacy Foundation/Lifespan.io, volunteered with SENS Research Foundation for the OncoSENS Program in Digital Strategy, and acted as Digital Strategy adviser at the Major Mouse Testing Program. He also functioned as the founder and former Board of Directors member of Astrum Fundación and was Digital Strategy Advisor for POKI Ciudad Orgánica. He is also a part of the General Member Board at the National Autism Association, the National Fibromyalgia Association, the International Literacy Association, and the United Spinal Association. Mr. De la Parra is also member of several associations for technology including: the World Blockchain Association, the Computing Technology Industry Association, the Internet Marketing Association, the Application Developers Alliance, and the Association of Strategic Marketing. Mr. De la Parra’s activities in arts & culture involve being the Digital Strategist and member of the Executive Board of Legado Cultural Siqueiros, a member of Sociedad de Autores y Compositores de México, while also being a member of the Executive Board at Sociedad Latinoamericana de Ópera. He also served as Digital strategy Advisor at Xicome Festival. He is a media professional at IMDB, SoundCloud and ReverbNation and has had activities in the entertainment industry as music producer, composer & arranger for Televisa with broadcast television, film, radio, and web, receiving international awards with aired content in more than 185 countries. For the energy sector, he worked as the Vice President of Strategy & Operations of PetroM Energy, and is a member of the National Introducing Brokers Association and a part of the National Biodiesel Board (Alliance Program).

Neuroscience, Regenerative Medicine, Continued Medical Education, Information & Communications Technology, Biotechnology, Social Development, and Renewable Energy Technologies.

Rashid Mahmood has Master Degree in Analytical Chemistry and MS in Total Quality Management. He has 15 years of experience of Pharmaceutical Quality Operations and has attended many international conferences as a keynote speaker. He has presented various talks in USA, Canada, UK and UAE on Cleaning Validation, cGMP Guidelines, Quality Risk Management, Role of Mass Spectrometry in Pharmaceuticals and on new Drug Delivery Systems. Currently he is working as a General Manager Technical Operations for Surge Lab.(Manufacturer of Microencapsulated APIs, Liquid & Dry Powder Parentrals) which is the best export oriented organization of Pakistan.

Rashid Mahmood studied Analytical Chemistry and has completed his MS in Total Quality Management from Punjab University Lahore-Pakistan. He joined Surge Laboratories Private Limited in 2004 and immediately excelled in his executive career track. He is working as DGM Technical Operations in one of the leading pharmaceutical company in Pakistan. His research interests include New Drug Delivery Systems, Quality Risk Management, Cleaning Validation, Microencapsulation, Pharmaceutics & Novel Drug Delivery Systems, Polymer Chemistry, Pharmaceutical cGMP & Hot Melt Extrusion.

Dr. M.R.Jayapal received Ph.D. in Synthetic Organic Electrochemistry from Sri Venkateswara University in 2010 and done M. Sc. in Organic Chemistry from Sri Venkateswara University in 2005. He started as an Assistant Professor in Chemistry in Institute of Aeronautical Engineering in 2011 and as an Assistant Professor in Chemistry and Head at Narasaraopeta Engineering college in 2013. After that joined as a Research scientist in National University of Cordoba in Argentina from 2015.to 2018. Presently working as a Talented Young scientist in YanCheng Institute of Technology in China.His interested research areas are Synthesis and Bioassay of Novel Heterocycles, A study on biologically potent Heterocycles, Synthesis of Nano particles and Synthesis, characterization and Electrochemical behaviour of chalcones ,Isoxazolins,Pyrazolins,Drugs and Pesticides of using D.C.Polarography, Differential pulse polarography,Cyclic Voltammetry, sensitive differential pulse adsorptive stripping voltammetric method ,Electro organic synthesis etc. He has been collaborated research work with South Africa and India various researchers. Dr.Jayapal published over 20 research publications and2 text book and communicated research papers are about 3and working as an Organizing committee member and Keynote speaker in many conferences.

His interested research areas are Synthesis and Bioassay of Novel Heterocycles, A study on biologically potent Heterocycles, Synthesis of Nano particles and Synthesis, characterization and Electrochemical behaviour of chalcones ,Isoxazolins,Pyrazolins,Drugs and Pesticides of using D.C.Polarography, Differential pulse polarography,Cyclic Voltammetry, sensitive differential pulse adsorptive stripping voltammetric method ,Electro organic synthesis etc.